How many stocks are there of Sysmex?
The current number of stocks of Sysmex is 626.43 M undefined.
Sysmex Stocks 2025
Sysmex Stocks
626.43 M
Ticker
6869.T
ISIN
JP3351100007
WKN
897966
In 2025, Sysmex had 626.43 M outstanding stocks, a 0% change from the 626.43 M stocks in the previous year.
The Sysmex Stocks history
| YEAR | NUMBER OF STOCKS (undefined JPY) |
|---|---|
| 2027e | 626.43 |
| 2026e | 626.43 |
| 2025e | 626.43 |
| 2024 | 626.43 |
| 2023 | 627.97 |
| 2022 | 628.43 |
| 2021 | 627.77 |
| 2020 | 208.97 |
| 2019 | 208.96 |
| 2018 | 208.8 |
| 2017 | 208.67 |
| 2016 | 208.59 |
| 2015 | 208.08 |
| 2014 | 207 |
| 2013 | 207 |
| 2012 | 206 |
| 2011 | 206 |
| 2010 | 205 |
| 2009 | 205 |
| 2008 | 205 |
| 2007 | 202 |
| 2006 | 202 |
| 2005 | 201 |
Sysmex shares outstanding JP3351100007 · 897966
The number of shares was Sysmex in 2024 — This indicates how many shares 626.425 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Sysmex earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Sysmex's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Sysmex’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sysmex's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2005 | 201 M Aktien |
| 2006 | 202 M Aktien |
| 2007 | 202 M Aktien |
| 2008 | 205 M Aktien |
| 2009 | 205 M Aktien |
| 2010 | 205 M Aktien |
| 2011 | 206 M Aktien |
| 2012 | 206 M Aktien |
| 2013 | 207 M Aktien |
| 2014 | 207 M Aktien |
| 2015 | 208.08 M Aktien |
| 2016 | 208.59 M Aktien |
| 2017 | 208.67 M Aktien |
| 2018 | 208.8 M Aktien |
| 2019 | 208.96 M Aktien |
| 2020 | 208.97 M Aktien |
| 2021 | 627.77 M Aktien |
| 2022 | 628.43 M Aktien |
| 2023 | 627.97 M Aktien |
| 2024 | 626.43 M Aktien |
| 2025e | 626.43 M Aktien |
| 2026e | 626.43 M Aktien |
| 2027e | 626.43 M Aktien |
Sysmex Aktienanalyse
What does Sysmex do?
Sysmex Corp is a Japanese company that has been a leading provider of diagnostic and analytical laboratory systems and solutions for the healthcare industry since its founding in 1968. The company is headquartered in Kobe, Japan and employs over 9,000 people worldwide. History: Sysmex was founded by a group of young scientists in Japan who wanted to develop an automated blood cell analysis system to improve the high workload of manual blood analysis at the time. The company began developing this system and brought it to market in 1972. Business model: Sysmex focuses on the development, production, and sale of diagnostic systems and solutions for medical laboratories around the world. The company specializes in hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology. Divisions: Sysmex Corp is divided into three main business divisions: 1. Diagnostic Systems: This division includes hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology systems. Sysmex is one of the world's leading providers of hematology analysis devices and also offers molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. 2. Information Solutions: This division offers software and IT solutions that support laboratory management and the integration of laboratory data to optimize analysis processes. The company also offers solutions for automating laboratory processes and managing laboratory inventory. 3. Life Science: This division focuses on the development of products for the life sciences, particularly cell analysis and imaging, as well as production, processing, and storage of cell cultures. Sysmex is also involved in the production of devices for harvesting mesenchymal stem cells from adipose tissue. Products: Sysmex offers a variety of products, including: - Hematology analysis devices for determining blood cell parameters such as RBC, WBC, HGB, HCT, and platelets. - Hemostasis systems for analyzing blood coagulation. - Molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. - Urinalysis systems for analyzing urine samples for chemical and microscopic parameters. - Immunology analysis devices for determining specific proteins and antibodies in the blood. - Clinical chemistry analysis devices for analyzing chemical parameters in blood samples. - Software and IT solutions for optimizing laboratory processes and management. - Cell analysis and imaging systems for investigating cell morphology and functions. - Devices for harvesting mesenchymal stem cells from adipose tissue. In summary, Sysmex Corp is a global leader in diagnostic and analytical laboratory systems and solutions for the healthcare industry. In its nearly 50-year history, the company has developed and produced a wide range of products that enable laboratories to perform fast and accurate disease diagnosis. The company has also expanded its business into other areas such as information solutions and the life sciences. Sysmex ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Sysmex's Shares Outstanding
Sysmex's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Sysmex’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Sysmex’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Sysmex’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Sysmex stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Sysmex are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Sysmex evolved in recent years?
The number of shares of Sysmex has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Sysmex as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Sysmex?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Sysmex pay?
Over the past 12 months, Sysmex paid a dividend of 29 JPY . This corresponds to a dividend yield of about 1 %. For the coming 12 months, Sysmex is expected to pay a dividend of 28.65 JPY.
What is the dividend yield of Sysmex?
The current dividend yield of Sysmex is 1 %.
When does Sysmex pay dividends?
Sysmex pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Sysmex?
Sysmex paid dividends every year for the past 23 years.
What is the dividend of Sysmex?
For the upcoming 12 months, dividends amounting to 28.65 JPY are expected. This corresponds to a dividend yield of 0.99 %.
In which sector is Sysmex located?
Sysmex is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sysmex kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sysmex from 6/1/2025 amounting to 15 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2025.
When did Sysmex pay the last dividend?
The last dividend was paid out on 6/1/2025.
What was the dividend of Sysmex in the year 2024?
In the year 2024, Sysmex distributed 42.667 JPY as dividends.
In which currency does Sysmex pay out the dividend?
The dividends of Sysmex are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Sysmex
Our stock analysis for Sysmex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sysmex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
